Supplemental material
Journal of Medical Economics
Volume 26, 2023 - Issue 1
Neurology
Evaluating the impact of early vs delayed ofatumumab initiation and estimating the long-term outcomes of ofatumumab vs teriflunomide in relapsing multiple sclerosis patients in Spain
Umakanth Vudumulaa Patient Access Services, Novartis Ireland Ltd, Dublin, Ireland
https://orcid.org/0000-0002-7407-4059View further author information
https://orcid.org/0000-0002-7407-4059View further author information, , , & Nicholas Adlardd Health Economics and Outcomes Research, Novartis Pharma AG, Basel, SwitzerlandCorrespondence[email protected]
https://orcid.org/0000-0001-6912-1685View further author information
https://orcid.org/0000-0001-6912-1685View further author information